Haim Ben-Ami
Technion – Israel Institute of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Haim Ben-Ami.
Canadian Journal of Gastroenterology & Hepatology | 2002
Haim Ben-Ami; Yeoshua Ginesin; Doron M. Behar; Doron Fisher; Yeouda Edoute; Alexandra Lavy
BACKGROUD: Urinary tract complications in Crohn’s disease are common but treatable, and often present diagnostic and therapeutic dilemmas.
The American Journal of the Medical Sciences | 1999
Haim Ben-Ami; Pradeep Nagachandran; Ahmad Assalia; Yeouda Edoute
We report a case of acute chylous ascites secondary to acute biliary pancreatitis, the first such case reported in the literature. Surprisingly, chylous ascites was detected during elective cholecystectomy. The pathogenesis and management of this problem is discussed.
Toxicology and Applied Pharmacology | 1991
Haim Ben-Ami; Shlomo Ben-Haim; Yequda Edoute; Gal Hayam; Uri Taitelman
Phosphamidon (2-chloro-3-(diethylamino)-1-methyl-3-oxopropanyldimethyl phosphate) is widely used in agriculture as an organophosphate insecticide. It is a water-soluble cholinesterase inhibitor whose estimated rat LD50 is 9.2 mg/kg, ip. Mechanical and electrophysiologic direct effects of phosphamidon were studied in an isolated working rat heart model. Phosphamidon caused a positive inotropic effect, as indicated by increased maximum time derivative of left ventricular pressure and increased cardiac output. Stroke work and total pressure-volume area increased in a dose-dependent manner following perfusion with phosphamidon. Phosphamidon had in this preparation a biphasic effect on heart rate: at 10(-6) M concentration, heart rate increased, but at higher concentrations (10(-4)-10(-3) M) heart rate decreased significantly. High concentrations of phosphamidon caused a significant prolongation of the Q-T interval. We conclude that phosphamidon has potent cardiotoxic effects, both mechanical and electrophysiologic, on the isolated rat heart.
The American Journal of the Medical Sciences | 2000
Haim Ben-Ami; Doron M. Behar; Yeouda Edoute; Alexandra Lavy; Yeoshua Ginesin; Doron Fischer
We report the case of a 35-year-old man who presented with fever, diarrhea, and a left abdominal mass. Diagnostic studies confirmed Crohn disease and revealed an abdominal mass obstructing the left ureter with hydroureter and hydronephrosis. The patient was successfully treated conservatively, with corticosteroids and mesalamine, A review of the literature indicates a predominance of right ureteral involvement in Crohn disease, associated with a high incidence of ileocecal disease. Most of these patients were treated surgically, with resection of ileocecal lesion and/or ureterolysis. Ureteral obstruction as a complication of Crohn disease is discussed, with emphasis on conservative treatment.
JAMA Internal Medicine | 1999
Haim Ben-Ami; Pradeep Nagachandran; Ayelet Mendelson; Yeouda Edoute
Journal of Cardiovascular Pharmacology | 2000
Yeouda Edoute; Pradeep Nagachandran; Boris Svirski; Haim Ben-Ami
American Journal of Medical Genetics | 2002
Doron M. Behar; Menachem Schlesinger; David Halle; Haim Ben-Ami; Yehouda Edoute; Eduardo Shahar; Imad Kasis; Shihab Shihab; Deborah Elstein; Ari Zimran; Hanna Mandel
Chest | 1988
Shlomo Ben-Haim; Haim Ben-Ami; Yeouda Edoute; N. Goldstien; D. Barzilai
Israel Medical Association Journal | 2001
Doron M. Behar; Shimon A. Reisner; Haim Ben-Ami
Israel Medical Association Journal | 2000
Doron M. Behar; Edelshtein S; Haim Ben-Ami; Mansano R; Yeouda Edoute